These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38869838)

  • 1. Evaluating the robustness of an AI pathfinder application on eligibility criteria in multiple myeloma trials using real-world data and historical trials.
    Jreich R; Zhang H; Meng Z; Wang F
    J Comp Eff Res; 2024 Jul; 13(7):e230164. PubMed ID: 38869838
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluating eligibility criteria of oncology trials using real-world data and AI.
    Liu R; Rizzo S; Whipple S; Pal N; Pineda AL; Lu M; Arnieri B; Lu Y; Capra W; Copping R; Zou J
    Nature; 2021 Apr; 592(7855):629-633. PubMed ID: 33828294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Clinical Trial Representativeness and Outcomes in Real-World Patients: Comparison of 6 Hallmark Randomized Clinical Trials of Relapsed/Refractory Multiple Myeloma.
    Chari A; Romanus D; Palumbo A; Blazer M; Farrelly E; Raju A; Huang H; Richardson P
    Clin Lymphoma Myeloma Leuk; 2020 Jan; 20(1):8-17.e16. PubMed ID: 31722839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative evaluation of the impact of relaxing eligibility criteria on the risk-benefit profile of drugs for lung cancer based on real-world data.
    Huang H; Jia S; Wang X; Miao H; Fang H; He H; Wu D; Tang Y; Li N
    Thorac Cancer; 2024 May; 15(14):1187-1194. PubMed ID: 38576119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity.
    Garcia S; Bisen A; Yan J; Xie XJ; Ramalingam S; Schiller JH; Johnson DH; Gerber DE
    J Thorac Oncol; 2017 Oct; 12(10):1489-1495. PubMed ID: 28802905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical Trials.
    Kaur M; Frahm F; Lu Y; Ascha MS; Guadamuz JS; Dotan E; Gottesman AS; Leybovich BC; Sondhi A; Zhao Y; Meropol NJ; Royce TJ
    NEJM Evid; 2024 Apr; 3(4):EVIDoa2300236. PubMed ID: 38771994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing the efficiency of trial-patient matching: automated clinical trial eligibility pre-screening for pediatric oncology patients.
    Ni Y; Wright J; Perentesis J; Lingren T; Deleger L; Kaiser M; Kohane I; Solti I
    BMC Med Inform Decis Mak; 2015 Apr; 15():28. PubMed ID: 25881112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Clinical Trial Participant Prescreening With Artificial Intelligence (AI): A Comparison of the Results of AI-Assisted vs Standard Methods in 3 Oncology Trials.
    Calaprice-Whitty D; Galil K; Salloum W; Zariv A; Jimenez B
    Ther Innov Regul Sci; 2020 Jan; 54(1):69-74. PubMed ID: 32008227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Real-World Data to Rationalize Clinical Trials Eligibility Criteria Design: A Case Study of Alzheimer's Disease Trials.
    Li Q; Guo Y; He Z; Zhang H; George TJ; Bian J
    AMIA Annu Symp Proc; 2020; 2020():717-726. PubMed ID: 33936446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated clinical trial eligibility prescreening: increasing the efficiency of patient identification for clinical trials in the emergency department.
    Ni Y; Kennebeck S; Dexheimer JW; McAneney CM; Tang H; Lingren T; Li Q; Zhai H; Solti I
    J Am Med Inform Assoc; 2015 Jan; 22(1):166-78. PubMed ID: 25030032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding Access to Lung Cancer Clinical Trials by Reducing the Use of Restrictive Exclusion Criteria: Perspectives of a Multistakeholder Working Group.
    Forde PM; Bonomi P; Shaw A; Blumenthal GM; Ferris A; Patel C; Melemed A; Basu Roy U; Ramamoorthy A; Liu Q; Burns T; Gainor JF; Lovly C; Piotrowska Z; Lehman J; Selig W
    Clin Lung Cancer; 2020 Jul; 21(4):295-307. PubMed ID: 32201247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of eligibility criteria in Alzheimer's and related dementias clinical trials.
    Mitchell AK; Ehrenkranz R; Franzen S; Han SH; Shakur M; McGowan M; Massett HA
    Sci Rep; 2024 Jul; 14(1):15036. PubMed ID: 38951633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Approach to Simplifying and Harmonizing Cancer Clinical Trials-Standardizing Eligibility Criteria.
    Gerber DE; Singh H; Larkins E; Ferris A; Forde PM; Selig W; Basu Roy U
    JAMA Oncol; 2022 Sep; 8(9):1333-1339. PubMed ID: 35925576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eligibility of real-world patients with metastatic breast cancer for clinical trials.
    Batra A; Kong S; Cheung WY
    Breast; 2020 Dec; 54():171-178. PubMed ID: 33120082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-Evaluating Eligibility Criteria for Oncology Clinical Trials: Analysis of Investigational New Drug Applications in 2015.
    Jin S; Pazdur R; Sridhara R
    J Clin Oncol; 2017 Nov; 35(33):3745-3752. PubMed ID: 28968168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Broadening Trial Eligibility Criteria for Patients with Advanced Non-Small Cell Lung Cancer: Real-World Analysis of Select ASCO-
    Harvey RD; Bruinooge SS; Chen L; Garrett-Mayer E; Rhodes W; Stepanski E; Uldrick TS; Ison G; Khozin S; Rubinstein WS; Schenkel C; Miller RS; Komatsoulis GA; Schilsky RL; Kim ES
    Clin Cancer Res; 2021 May; 27(9):2430-2434. PubMed ID: 33563634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of research on eligibility criteria for clinical trials.
    Su Q; Cheng G; Huang J
    Clin Exp Med; 2023 Oct; 23(6):1867-1879. PubMed ID: 36602707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated classification of eligibility criteria in clinical trials to facilitate patient-trial matching for specific patient populations.
    Zhang K; Demner-Fushman D
    J Am Med Inform Assoc; 2017 Jul; 24(4):781-787. PubMed ID: 28339690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of idecabtagene vicleucel in patients with relapsed-refractory multiple myeloma not meeting the KarMMa-1 trial eligibility criteria: A real-world multicentre study.
    Dima D; Rashid A; Davis JA; Shune L; Abdallah AO; Li H; DeJarnette S; Khouri J; Williams L; Hashmi H; Raza S; McGuirk J; Anwer F; Ahmed N
    Br J Haematol; 2024 Apr; 204(4):1293-1299. PubMed ID: 38263627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.